Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

You are here: Home / Statistics / Comparative statistics by cancer site (ICD-10)

Comparative statistics by cancer site (ICD-10)

ICD-10: Comparative statistics by registry

Table 5b: Proportion (%) of cases and 5-year absolute survival by extent of disease and site

Click on country-registry for comparison

Flag	Country-registry	Registration period	Number of case	% of cases by extent of disease				5-year absolute survival %
Flag	Country-registry	Registration period	Number of case	Localized	Regional	Dis. Met.	Unknown	Localized	Regional	Dis. Met.	Unknown
	Cuba	1994-1995	260	44.2	34.6	0.4	20.8	52.6	22.2	0.0	24.4
	India - Bhopal	1991-1995	172	40.7	55.8	0.6	2.9	45.7	17.7	0.0	20.0
	India - Chennai	1990-1999	1662	3.5	88.7	2.7	5.0	54.9	30.0	10.0	30.9
	India - Karunagappally	1991-1997	123	14.6	65.9	12.2	7.3	83.0	28.5	0.0	38.2
	India - Mumbai	1992-1994	2769	32.6	55.8	6.9	4.6	62.5	18.0	1.1	35.5
	Pakistan - South Karachi	1995-1999	413	36.3	53.0	0.5	10.2	58.3	18.6	0.0	18.3
	Singapore	1993-1997	135	28.1	22.2	1.5	48.2	52.2	26.3	0.0	28.9
	Thailand - Lampang	1990-2000	118	21.2	66.1	4.2	8.5	35.6	30.7	0.0	40.0

Graphs:

5-year absolute survival by extent of disease: localized:
sort by country / sort by survival

5-year absolute survival by extent of disease: regional:
sort by country / sort by survival

5-year absolute survival by extent of disease: distant metastasis:
sort by country / sort by survival

5-year absolute survival by extent of disease: unknown:
sort by country / sort by survival

Other tables available:

- Table 1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
- Table 2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
- Table 2b:	Number and proportion of cases by vital status and median follow-up (in months) by site
- Table 3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site
- Table 4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group
- Table 5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site
- Table 6:	Comparison of 5-year absolute and relative survival of cases diagnosed
- Table 7b:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 8:	Up-to-date 5-year relative survival estimates using cohort and period approaches by site and calendar period
- Table 9:	Up-to-date 10- and 15-year relative survival estimates using cohort and period approaches by site and calendar period